Objective:To investigate the disease self-management status of patients with chronic obstructive pulmonary disease (COPD) and its influential factors, providing evidence for the development of effective management strategies.Methods:A total of 483 patients with chronic obstructive pulmonary disease (COPD) who received treatment at Wenshan People's Hospital from April 2023 to April 2024 were included in this study. Their disease self-management status was assessed, and one-way analysis of variance and multiple linear regression analysis were conducted to identify the factors influencing patients' self-management abilities.Results:Among the 483 patients studied, only 2.9% (14/483) showed a complete understanding of their disease, while 21.12% (102/483) had some understanding of how to manage it. Only 34.38% (166/483) of the patients used inhalants outside the hospital as required, of which only 40.96% (68/166) used them regularly as required by doctors, and 60.84% (101/106) of the patients inhaled correctly. One-way analysis of variance and multiple linear regression analysis results showed that the factors affecting patients' self-management included COPD classification, smoking, life satisfaction, disease self-cognition, exercise habits, lung function, and gender ( t = 2.35, -2.22, -5.76, 4.37, -2.22, 5.09, -3.64, all P < 0.05). Conclusions:Patients with COPD exhibit poor disease self-management awareness and medication compliance. Patient's ability to self-manage their disease is associated with COPD classification, lung function, smoking, exercise habits, gender, life satisfaction, and disease self-cognition. Therefore, it is essential to develop appropriate intervention measures based on these factors, focusing on enhancing patients' self-management awareness and abilities to improve their quality of life.

Objective:To investigate the disease self-management status of patients with chronic obstructive pulmonary disease (COPD) and its influential factors, providing evidence for the development of effective management strategies.Methods:A total of 483 patients with chronic obstructive pulmonary disease (COPD) who received treatment at Wenshan People's Hospital from April 2023 to April 2024 were included in this study. Their disease self-management status was assessed, and one-way analysis of variance and multiple linear regression analysis were conducted to identify the factors influencing patients' self-management abilities.Results:Among the 483 patients studied, only 2.9% (14/483) showed a complete understanding of their disease, while 21.12% (102/483) had some understanding of how to manage it. Only 34.38% (166/483) of the patients used inhalants outside the hospital as required, of which only 40.96% (68/166) used them regularly as required by doctors, and 60.84% (101/106) of the patients inhaled correctly. One-way analysis of variance and multiple linear regression analysis results showed that the factors affecting patients' self-management included COPD classification, smoking, life satisfaction, disease self-cognition, exercise habits, lung function, and gender ( t = 2.35, -2.22, -5.76, 4.37, -2.22, 5.09, -3.64, all P < 0.05). Conclusions:Patients with COPD exhibit poor disease self-management awareness and medication compliance. Patient's ability to self-manage their disease is associated with COPD classification, lung function, smoking, exercise habits, gender, life satisfaction, and disease self-cognition. Therefore, it is essential to develop appropriate intervention measures based on these factors, focusing on enhancing patients' self-management awareness and abilities to improve their quality of life.

OBJECTIVE:To study the bioequivalences of both domestic nevirapine capsules and imported nevirapine tablets.METHODS:24healthy male volunteers were administered orally with single dose of either the domestic nevirapine trial capsules or the imported nevirapine reference tablets by randomized crossover way,the blood concentration of nevirapine was determined by HPLC,and the pharmacokinetics parameters and the relative bioavailability of whom were calculated.RE?SULTS:The C max of the trial preparation and the reference preparation were(2.516?0.446)?g/ml and(2.798?0.394)?g/ml,respectively t max were(7.5?10.7)and(3.6?2.1)h,t 1/2 were(51.4?25.3)h and(46.4?9.8)h;AUC 0～168 were(160.540?38.007)(?g?n)/ml and(167.459?30.629)(?g?n)/ml;AUC 0～∞ were(180.064?51.005)(?g?n)/ml and(183.052?36.828)(?g?n)/ml;The relative bioavailability of the trial preparation was(98.368?22.99)%.CONCLUSION:The results shows that the trial preparation and the reference preparation of nevirapine were bioequivalent.